Drugs Health Medical

Human tears: Is it a natural antidote to male aggression?

HQ team January 1, 2024: A new study done by the Weizmann Institute of Science in Israel looks into how human female tears.

Read More
Drugs Health Pharma

Cytisine, an effective affordable smoking cessation aid, faces accessibility hurdles

HQ Team January 1, 2024: Smoking is injurious to health is an accepted fact by smokers even, and figures say that nine out.

Read More
Drugs Health Pharma

Opinion: Covid-19 variant needs cautious vigilance, not undue panic

By K. Leelamoni The coronavirus variant JN. 1 has been causing concern among health experts and the public alike. JN.1 is surging in.

Read More
Drugs Health Pharma

Bristol Myers to acquire Karuna Therapeutics for $14 billion

HQ Team December 23, 2023: Bristol Myers Squibb will buy US-based biotech company, Karuna Therapeutics for $14 billion to expand its neuroscience portfolio,.

Read More
Drugs Health Pharma

USFDA clears AstraZeneca-Ionis’ drug for nervous system impairment

HQ Team December 22, 2023: Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to.

Read More
Drugs Health Pharma

FDA starts crackdown against fake Ozempic weight-loss drug 

HQ Team December 22, 2023: The FDA has seized “thousands of units” of counterfeit weight-loss injection Ozempic which have no information about the.

Read More
Drugs Health Pharma

WHO places second malaria jab on ‘list of prequalified vaccines’

HQ Team December 21, 2023: The World Health Organization has added a second malaria vaccine to its list of prequalified vaccines to enable.

Read More
Drugs Health Pharma

Noma added to WHO’s list of 21 neglected tropical diseases 

HQ Team December 21, 2023: The WHO, has included noma in its official list of neglected tropical diseases to expand health services to.

Read More
Drugs Health Pharma

Sweden’s Calliditas gets FDA nod for oral drug to treat kidney loss function

HQ Team December 21, 2023: Sweden’s Calliditas Therapeutics has got the USFDA green light for its oral drug to treat loss of kidney.

Read More
Drugs Health Pharma

Recall of Philips imaging devices ‘most serious’: USFDA says

HQ Team December 21, 2023: The US drug regulator has termed its Class I recall of Philips magnetic resonance systems as the “most.

Read More